A/Pr Nicholas Wilcken

Related Grants and Projects

• Participant in A Multi-site study of Tamoxifen dose escalation study in breast cancer patients with CYP2D6 polymorphisms (TADE study) (funded by National Health and Medical Research Council)
• Participant in Breast Cancer Biospecimen Resource (funded by National Health and Medical Research Council)
• Participant in CAPTURE: Circulating tumour DNA assessment of PIK3CA to guide treatment response (funded by National Health and Medical Research Council)
• Participant in POSNOC (Positive Sentinel Node – a randomised trial of adjuvant therapy alone versus adjuvant therapy plus Clearance or axillary radiotherapy) (funded by National Health and Medical Research Council)
• Participant in Randomised phase II trial of neoadjuvant chemotherapy +/- concurrent aromatase inhibitor endocrine therapy to down-stage large oestrogen receptor positive breast cancer (funded by National Health and Medical Research Council)
• View all 7 related grants and projects